Could a simple vaccine cut infant deaths? trial investigates
NCT ID NCT02504203
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether giving the BCG vaccine (normally given later) right after birth could reduce deaths in babies under 2 months old. Over 2,300 newborns in rural and urban areas took part. The trial was stopped early, so we don't have final answers yet.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BCG vaccine (Bacillus Calmette-Guérin)
- What this could lead to
- If it works, giving BCG earlier could save many newborn lives in areas with high infant mortality.
- What could go wrong
- The trial was terminated early, so results are limited. The effect may vary by setting and not be as strong as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BCG are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bandim Health Project
Bissau, Guinea-Bissau
More trials for these conditions
Other studies related to the condition(s) this trial covers.